Letrozole is a non-steroidal aromatase inhibitor used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. The drug works by lowering estrogen levels in the body, which can slow or stop the growth of certain types of breast cancer cells that require estrogen to grow.
The Letrozole market is anticipated to reach USD xx billion by 2034, growing at a...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian